Patient-reported outcomes in patients co-infected with hepatitis C virus and human immunodeficiency virus treated with sofosbuvir and velpatasvir: The ASTRAL-5 study.

Find People
Find Research
Overview
Tutorials
FAQs
Edit My PROFILE
Login to PROFILES

Contact Us
If you have any questions or feedback please contact us.

Patient-reported outcomes in patients co-infected with hepatitis C virus and human immunodeficiency virus treated with sofosbuvir and velpatasvir: The ASTRAL-5 study.

Younossi ZM, Stepanova M, Sulkowski M, Wyles D, Kottilil S, Hunt S. Patient-reported outcomes in patients co-infected with hepatitis C virus and human immunodeficiency virus treated with sofosbuvir and velpatasvir: The ASTRAL-5 study. Liver Int. 2017 12; 37(12):1796-1804.

View in: PubMed

subject areas

Antiviral Agents
Carbamates
Case-Control Studies
Cohort Studies
Coinfection
Drug Combinations
Female
Hepatitis C
Heterocyclic Compounds, 4 or More Rings
HIV Infections
Humans
Male
Middle Aged
Patient Reported Outcome Measures
Sofosbuvir

authors with profiles

David L. Wyles

Contact Us
CCTSI
About CCTSI
CCTSI Affiliated Institutions
National CTSA Consortium